This job has expired

This position was posted on April 2, 2026 and is likely no longer accepting applications. We've kept it here for historical reference. Check out the similar jobs below!

Medical Director, MDS

AskBio Inc.

Job Overview

Location

Remote US

Job Type

Full-time

Full Job Description

📋 Description

• As Medical Director, Movement Disorders Specialist for the GDNF Program at AskBio Inc., you will provide strategic and hands-on clinical leadership for gene therapy programs targeting CNS movement disorders across Phase 1–3 development, ensuring scientific rigor, patient safety, and regulatory compliance while advancing transformative therapies for debilitating neurological conditions.
• You will drive the overall clinical development strategy for the GDNF gene therapy program, serve as the Parkinson’s clinical expert in randomized, double-blind trials, lead protocol design and endpoint strategy, provide medical oversight for trial execution, lead risk–benefit assessments, support regulatory interactions, oversee long-term follow-up strategies, mentor clinical teams, partner with cross-functional functions, present data to leadership and external stakeholders, ensure inspection readiness, foster KOL relationships, integrate clinical development with commercial and research teams, and represent AskBio at scientific forums and advisory boards.
• AskBio Inc. is a wholly owned, independently operated subsidiary of Bayer AG and a fully integrated gene therapy company dedicated to developing life-saving medicines for neuromuscular, CNS, cardiovascular, and metabolic diseases, with a clinical-stage pipeline including investigational therapeutics for Parkinson’s disease, limb-girdle muscular dystrophy, multiple system atrophy, congestive heart failure, and Pompe disease, backed by a proprietary gene therapy platform featuring Pro10™ cell line manufacturing and extensive capsid/promoter libraries.
• You will join a mission-driven organization guided by pioneering science, collaboration, responsibility, continuous improvement, and integrity, where you can advance your expertise in gene therapy and movement disorders, influence global clinical strategy, contribute to first-in-human and registrational trials, and help bring transformative treatments to patients in need while growing as a clinical leader in a cutting-edge biotech environment.

🎯 Requirements

• MD from an accredited U.S. medical school or equivalent international medical degree with 6+ years of relevant clinical experience treating Movement Disorders patients
• Board certification or eligibility in Neurology or a closely related specialty with movement disorders specialization and completion of clinical training
• Minimum of two years of industry experience in clinical development within pharmaceutical, biotechnology, medical device, or CRO/CDMO environments
• Demonstrated leadership in designing and executing clinical trials across multiple phases, including oversight of clinical monitoring activities
• Proven experience supporting FDA or global health authority inspections, audits, or formal inspection readiness initiatives
• Working knowledge of GCP, regulatory requirements, and trial quality management systems
• Ability to independently lead clinical programs and make program-level medical decisions in a regulated development environment
• Strong strategic leadership and cross-functional influence
• Ability to support FDA inspection readiness activities, including review of critical trial documentation, monitoring outputs, and CAPAs
• Expertise in risk-based monitoring and clinical trial quality oversight
• Strong analytical judgment applied to complex clinical and safety issues
• Excellent communication and executive presentation skills
• Ability to operate effectively in a fast-paced, evolving biotech environment
• Proven track record of successful clinical program leadership, including advancing programs through critical development milestones
• Exceptional strategic and operational planning skills, with the ability to translate long-term vision into executable clinical plans
• Strong leadership presence with the ability to influence, inspire, and align cross-functional teams
• Established professional network within the gene therapy and/or CNS development community
• Understanding of market dynamics, competitive landscape, and evolving trends relevant to gene therapy and movement disorders

🏖️ Benefits

• Opportunity to lead clinical development for innovative gene therapies targeting serious movement disorders with potential to transform patient lives
• Access to AskBio’s industry-leading gene therapy platform, including Pro10™ manufacturing and proprietary capsids/promoters
• Collaboration with a global team backed by Bayer AG’s resources and commitment to scientific excellence
• Engagement in high-impact scientific forums, advisory boards, and conferences as a clinical and scientific leader
• Professional growth through mentoring clinical teams and contributing to organizational capability building in gene therapy and CNS development

Skills & Technologies

Express

GCP

Remote

Ready to Apply?

Apply Externally

You will be redirected to an external site to apply.

AskBio Inc.

Visit Website

About AskBio Inc.

AskBio Inc. is a biotechnology company developing adeno-associated virus (AAV)-based gene therapies for rare genetic diseases, neuromuscular and central nervous system disorders. Founded in 2001 by Jude Samulski, the company operates a proprietary AAV technology platform, scalable manufacturing facilities, and a pipeline spanning pre-clinical to late-stage clinical programs. AskBio was acquired by Bayer in 2020 and continues to operate as its wholly owned subsidiary, advancing investigational treatments for conditions such as Pompe disease, Huntington’s disease and heart failure.

View Company Profile

Get more remote jobs like this

Subscribe to the weekly newsletter for similar remote roles and curated hiring updates.

Weekly remote jobs and featured talent.

No spam. Only curated remote roles and product updates. You can unsubscribe anytime.